Lyell Immunopharma, Inc. (LYEL) · INSIDERData sourcesSEC Form 458m ago
House PTR58m ago
SEC 13F58m ago
Robinhood Chain58m ago
Public companyLyell Immunopharma, Inc.
LYELCIK 0001806952
Price$14.86
1 year-10.2%
Disclosed transactions28
Buys / sells0 / 21
Max Insider Score37
Connections with evidence6
LYEL · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 21 | AMAguirre Jarrad MattieuChief Medical Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $3,642 422 sh | Oct 12, 2026 |
| Oct 13, 2026 traded Oct 12, 2026 |
| 9 | AMAguirre Jarrad MattieuChief Medical Officer | LYELLyell Immunopharma, Inc. Grant or award | A | — 47.5K sh | Sep 10, 2026 | Sep 10, 2026 traded Sep 10, 2026 | +0d | SEC Form 4 | |
| 17 | SDShook DavidChief Medical Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $6,350 500 sh | Sep 10, 2026 | Sep 10, 2026 traded Sep 10, 2026 | +0d | SEC Form 4 | |
| 31 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $23K 1,457 sh | Aug 21, 2026 | Aug 25, 2026 traded Aug 21, 2026 | +4d | SEC Form 4 | |
| 31 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $15K 989 sh | Aug 21, 2026 | Aug 25, 2026 traded Aug 21, 2026 | +4d | SEC Form 4 | |
| 27 | BSBulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $8,905 621 sh | Aug 10, 2026 | Aug 11, 2026 traded Aug 10, 2026 | +1d | SEC Form 4 | |
| 27 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $1,879 131 sh | Aug 10, 2026 | Aug 11, 2026 traded Aug 10, 2026 | +1d | SEC Form 4 | |
| 27 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $1,276 89 sh | Aug 10, 2026 | Aug 11, 2026 traded Aug 10, 2026 | +1d | SEC Form 4 | |
| 37 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $1,684 89 sh | May 11, 2026 | Jun 15, 2026 traded May 11, 2026 | +35d | SEC Form 4 | |
| 37 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $2,460 130 sh | May 11, 2026 | Jun 15, 2026 traded May 11, 2026 | +35d | SEC Form 4 | |
| 37 | BSBulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $4,103 217 sh | May 11, 2026 | Jun 15, 2026 traded May 11, 2026 | +35d | SEC Form 4 | |
| 25 | SDShook DavidChief Medical Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $25K 1,977 sh | Jun 10, 2026 | Jun 11, 2026 traded Jun 10, 2026 | +1d | SEC Form 4 | |
| 31 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $39K 1,671 sh | Feb 11, 2026 | Feb 12, 2026 traded Feb 11, 2026 | +1d | SEC Form 4 | |
| 31 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $29K 1,236 sh | Feb 11, 2026 | Feb 12, 2026 traded Feb 11, 2026 | +1d | SEC Form 4 | |
| 13 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Grant or award | A | — 4,000 sh | Feb 9, 2026 | Feb 11, 2026 traded Feb 9, 2026 | +2d | SEC Form 4 | |
| 5 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Grant or award | A | — 50.0K sh | Feb 10, 2026 | Feb 11, 2026 traded Feb 10, 2026 | +1d | SEC Form 4 | |
| 27 | BSBulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $5,872 254 sh | Feb 10, 2026 | Feb 11, 2026 traded Feb 10, 2026 | +1d | SEC Form 4 | |
| 17 | BSBulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Grant or award | A | — 8,750 sh | Feb 10, 2026 | Feb 11, 2026 traded Feb 10, 2026 | +1d | SEC Form 4 | |
| 9 | SDShook DavidChief Medical Officer | LYELLyell Immunopharma, Inc. Grant or award | A | — 50.0K sh | Feb 10, 2026 | Feb 11, 2026 traded Feb 10, 2026 | +1d | SEC Form 4 | |
| 27 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $2,520 109 sh | Feb 10, 2026 | Feb 11, 2026 traded Feb 10, 2026 | +1d | SEC Form 4 | |
| 13 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Grant or award | A | — 4,000 sh | Feb 9, 2026 | Feb 11, 2026 traded Feb 9, 2026 | +2d | SEC Form 4 | |
| 5 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Grant or award | A | — 65.0K sh | Feb 10, 2026 | Feb 11, 2026 traded Feb 10, 2026 | +1d | SEC Form 4 | |
| 27 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $3,399 147 sh | Feb 10, 2026 | Feb 11, 2026 traded Feb 10, 2026 | +1d | SEC Form 4 | |
| 27 | BSBulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $30K 936 sh | Dec 30, 2025 | Jan 6, 2026 traded Dec 30, 2025 | +7d | SEC Form 4 | |
| 31 | BSBulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $44K 1,136 sh | Dec 24, 2025 | Jan 6, 2026 traded Dec 24, 2025 | +13d | SEC Form 4 | |
| 31 | HJHill Stephen J.Chief Operating Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $1,531 95 sh | Nov 10, 2025 | Nov 12, 2025 traded Nov 10, 2025 | +2d | SEC Form 4 | |
| 31 | BSBulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $3,848 239 sh | Nov 10, 2025 | Nov 12, 2025 traded Nov 10, 2025 | +2d | SEC Form 4 | |
| 31 | LKLee Gary K.Chief Scientific Officer | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $2,230 138 sh | Nov 10, 2025 | Nov 12, 2025 traded Nov 10, 2025 | +2d | SEC Form 4 | |
VP, Corporate Controller · Nov 12, 2025